10-KPeriod: FY2021

UNITEDHEALTH GROUP INC Annual Report, Year Ended Dec 31, 2021

Filed February 15, 2022For Securities:UNH

Summary

UnitedHealth Group Inc. (UNH) reported strong financial performance for the fiscal year ending December 31, 2021. The company demonstrated robust revenue growth, increasing by 12% year-over-year, driven by expansion in both its UnitedHealthcare and Optum segments. UnitedHealthcare saw a 11% revenue increase, largely due to growth in Medicare Advantage, Medicaid, and commercial offerings, serving approximately 2.1 million more people domestically. The Optum segment exhibited even stronger growth with a 14% revenue increase, particularly fueled by Optum Health's 36% revenue surge from value-based care and acquisitions, alongside solid performance in Optum Insight and Optum Rx. Net earnings attributable to common shareholders grew by 12% to $17.3 billion, or $18.08 per diluted share. The company's return on equity remained strong at 25.2%. UnitedHealth Group also generated substantial cash flow from operations, amounting to $22.3 billion, which supported significant investments in acquisitions, share repurchases, and dividend payments. The company returned $10.3 billion to shareholders through dividends and share repurchases, underscoring its commitment to shareholder value. The report also highlights the company's ongoing investments in technology and care delivery models, positioning it for continued growth in the evolving healthcare landscape.

Financial Highlights

57 data points
Beta

Revenue

$287.60B

89.2% Gross Margin

Net Income

$17.29B

6.0% Net Margin

EPS (Diluted)

$18.08

Total Assets

$212.21B

Cash & Equivalents

$21.38B

Free Cash Flow

$19.89B

Financial Statements
Beta
Revenue$287.60B
Cost of Revenue$31.03B
Gross Profit$256.56B
SG&A Expenses$42.58B
Operating Expenses$263.63B
Operating Income$23.97B
Interest Expense$1.66B
Net Income$17.29B
EPS (Basic)$18.33
EPS (Diluted)$18.08
Shares Outstanding (Basic)943.00M
Shares Outstanding (Diluted)956.00M

Key Highlights

  • 1Total revenues increased by 12% to $287.6 billion, driven by growth across both UnitedHealthcare and Optum segments.
  • 2Net earnings attributable to common shareholders increased by 12% to $17.3 billion, with diluted earnings per share rising to $18.08.
  • 3UnitedHealthcare served approximately 2.1 million more people domestically, with Medicare Advantage and Medicaid programs showing significant enrollment growth.
  • 4Optum segment revenues grew by 14%, with Optum Health showing a substantial 36% increase, indicating strong performance in care delivery and value-based care.
  • 5Cash flows from operations were robust at $22.3 billion, providing ample resources for acquisitions, share repurchases, and dividend payments.
  • 6The company returned $10.3 billion to shareholders through dividends ($5.3 billion) and share repurchases ($5.0 billion).
  • 7Return on equity remained strong at 25.2%, reflecting efficient capital utilization.

Frequently Asked Questions

Revenue growth was primarily driven by an increase in the number of individuals served across its UnitedHealthcare and Optum segments. This included growth in Medicare Advantage, Medicaid, and commercial offerings, as well as organic and acquisition growth within the Optum businesses, particularly in care delivery and health financial services.

The COVID-19 pandemic had a mixed impact. While it led to increased COVID-19 related care and testing costs, and negatively affected certain Optum services due to reduced clinical activity, it was partially offset by the temporary deferral of care by consumers. The company anticipates that deferred care may lead to higher future utilization.

UnitedHealth Group demonstrated a strong commitment to shareholder returns by increasing its quarterly dividend to an annual rate of $5.80 per share and repurchasing approximately $5.0 billion of its common stock during 2021. In total, the company returned $10.3 billion to shareholders.

The Optum segment delivered impressive growth, with revenues increasing by 14%. Optum Health saw a significant 36% revenue increase due to organic growth in value-based arrangements and acquisitions in care delivery. Optum Insight and Optum Rx also contributed positively with revenue increases of 13% and 4%, respectively, driven by growth in technology, services, and script volumes.